🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsOral semaglutide bioavailability optimization — 12 month update Page 3

Oral semaglutide bioavailability optimization — 12 month update

jim_asheville Wed, Feb 7, 2024 at 4:58 PM 58 replies 3,516 viewsPage 3 of 12
AmyNC_wife
Member
634
2,890
Jun 2024
North Carolina
Feb 7, 2024 at 9:13 PM#11

+1 to Dr.ObesityLA. Especially the point about "Re: Oral semaglutide — the subgroup anal..." — I have seen the same in my own experience with Oral semaglutide.

Last edited: Feb 7, 2024 at 10:13 PM
2 2JessicaM_2024, TomFromTexas
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Feb 7, 2024 at 9:30 PM#12

Want to share my personal experience related to Oral semaglutide since I think it might help others in a similar situation.

I started my GLP-1 journey in March 2025 at 255 lbs with metabolic syndrome. My telehealth provider prescribed semaglutide 0.25mg to start.

Now, 8 months later: I am down 50 lbs, my labs have normalized, and my sleep apnea has improved dramatically. The Oral semaglutide aspect specifically was something that made a big difference in my journey.

This forum was my go-to resource throughout.

30 12RunnerRach, TrialNerd_Beth, HPLC_Greg and 27 others
Reply Quote Save Share Report
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Feb 7, 2024 at 9:47 PM#13

Dr.ObesityMed — that is really helpful context on Oral semaglutide. Follow-up question: did you change anything about your diet at the same time?

I am in a similar situation (month 2) and trying to set realistic expectations.

2 12COA_Karl, MikeFit_NJ
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Feb 7, 2024 at 10:04 PM#14

To answer pete_manc_UK's question specifically:

From a clinical standpoint, Oral semaglutide is well-supported by the literature.

The short answer: follow the standard titration protocol and reassess at 4-6 weeks.

The longer answer involves pharmacokinetic considerations around steady-state concentrations, which I am happy to elaborate on if helpful.

Last edited: Feb 8, 2024 at 12:04 AM
48 22B12Beth, RickReta_CO, PharmHunterJen and 45 others
Reply Quote Save Share Report
oliver_london
Member
312
1,345
Aug 2024
London, UK
Feb 7, 2024 at 10:21 PM#15

Saving this for reference. Top-tier content.

13 12wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 10 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register